Alto Neuroscience Statistics

Total Valuation

ANRO has a market cap or net worth of $104.91 million. The enterprise value is -$61.30 million.

Market Cap	104.91M
Enterprise Value	-61.30M

Important Dates

The next estimated earnings date is Sunday, February 2, 2025, before market open.

Earnings Date	Feb 2, 2025
Ex-Dividend Date	n/a

Share Statistics

ANRO has 26.97 million shares outstanding. The number of shares has increased by 408.92% in one year.

Current Share Class	26.97M
Shares Outstanding	26.97M
Shares Change (YoY)	+408.92%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	8.27%
Owned by Institutions (%)	63.55%
Float	19.40M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.64
P/TBV Ratio	0.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.09, with a Debt / Equity ratio of 0.09.

Current Ratio	13.09
Quick Ratio	12.96
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-45.33

Financial Efficiency

Return on equity (ROE) is -56.72% and return on invested capital (ROIC) is -34.75%.

Return on Equity (ROE)	-56.72%
Return on Assets (ROA)	-32.36%
Return on Capital (ROIC)	-34.75%
Revenue Per Employee	n/a
Profits Per Employee	-$857,418
Employee Count	67
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	5.74
200-Day Moving Average	11.03
Relative Strength Index (RSI)	38.98
Average Volume (20 Days)	318,732

Short Selling Information

The latest short interest is 4.08 million, so 15.12% of the outstanding shares have been sold short.

Short Interest	4.08M
Short Previous Month	4.61M
Short % of Shares Out	15.12%
Short % of Float	21.01%
Short Ratio (days to cover)	8.36

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-63.38M
Pretax Income	n/a
Net Income	-57.45M
EBITDA	-62.93M
EBIT	-63.38M
Earnings Per Share (EPS)	-$3.05

Full Income Statement

Balance Sheet

The company has $181.70 million in cash and $15.49 million in debt, giving a net cash position of $166.21 million or $6.16 per share.

Cash & Cash Equivalents	181.70M
Total Debt	15.49M
Net Cash	166.21M
Net Cash Per Share	$6.16
Equity (Book Value)	165.05M
Book Value Per Share	6.12
Working Capital	169.51M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.93 million and capital expenditures -$1.92 million, giving a free cash flow of -$47.85 million.

Operating Cash Flow	-45.93M
Capital Expenditures	-1.92M
Free Cash Flow	-47.85M
FCF Per Share	-$1.77

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ANRO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-408.92%
Shareholder Yield	-408.92%
Earnings Yield	-54.76%
FCF Yield	-45.61%

Analyst Forecast

The average price target for ANRO is $19.67, which is 405.66% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.67
Price Target Difference	405.66%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3